• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthritis (1723); Unspecified Infection (1930); Neuropathy (1983); Seroma (2069); Impaired Healing (2378); Joint Laxity (4526)
Event Date 01/01/2020
Event Type  Injury  
Manufacturer Narrative
Product complaint #(b)(4).If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that any of the ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with any of the ethicon products used in this procedure? if so, please provide details.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Patient demographics? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.(b)(4).The single complaint was reported with multiple events.There are no additional details regarding the additional events.Related events captured via 2210968-2021-10855.Citation: archives of orthopaedic and trauma surgery (2021) 141:1101¿1108 https://doi.Org/10.1007/s00402-020-03504-5.
 
Event Description
Title: complications after sternoclavicular surgery the aim of this study was to examine the complications after scj surgery, and especially the incidence of infections.A total of 68 consecutive patients who had a first-time scj surgery in our clinic were included.One of these patients had already had scj surgery in another clinic.The cohort consisted of 22 men and 46 women who had a mean age of 37.5 years (range, 13-70 years).The indication for surgery was osteoarthritis in 27 of 68 patients (39.7%), instability in 37 (54.4%), and other indications in 4 patients (5.9%).In the reconstructive surgery cases, a combination of hamstring tendon with a pds band was mostly used.Primary stabilization of the scj was performed with a hamstring autograft combined with a polydioxanone suture (pds) (ethicon, inc, somerville, nj, usa) in mainly all cases.This technique was also executed in the case of an mcr.An anterior transverse incision was made across the medial aspect of the clavicle to the manubrium.The medial aspect of the clavicle was subperiosteally exposed and the scj was identified.A small incision was made in the capsule, providing room for inspection of the cartilaginous disc.Osteophytes, calcifications, and scar tissue were removed.Four 4-mm-diameter v-shaped drill holes were made, 2 in the manubrium and 2 at the medial end of the clavicle, spaced 1 cm apart.First, the previously harvested tendon was passed through the inner drill holes of the clavicle, crossing the joint, and passed through the hole in the manubrium.Then, the ligament was crossed back, in a figure-of-8 form, through the same hole in the clavicle, then brought under manual tension, and the endings were sutured to each other with a pds- 0 wire.In the same manner, a pds band was passed through the outer drill holes and sutured with the pds-0 wire to each other in the center.After closure of the capsule and closing of the overlying muscle, the wound was closed using a 4-0 monocryl skin suture (ethicon, inc.).Of the 68 scj surgeries that were performed, an infection occurred in 16 patients (23.5%).Eight of these occurred within 6 weeks after surgeryd11.8% of the whole cohort.Complications such as wound healing problems and scar tissue problems were seen in 5 cases at the scj surgical site, of which 1 underwent a needle drainage of a seroma and 3 at the donor site.One of the latter resulted in saphenous nerve neuropathy due to a seroma.Two frozen shoulders were seen.A total of 26 reoperations (14 due to clinical signs of infection, 9 due to instability, 1 due to osteoarthritis,2 due to other causes) were performed in our cohort.Seven of the infected cases needed multiple surgeries to eradicate the pathogen and achieve an acceptable clinical situation.Five of these 7 needed revision of fixation after treatment for infection.One scj remained unstable, even after revision surgery.Postoperative complications included n=16 infections, n=5 wound healing problems and scar tissue problems at the scj surgical site, n=1 osteoarthritis and n=9 recurrent instability.In conclusion, complications after scj surgery occur more often than previously described.C.Acnes infections are often seen.When left untreated, these complications can lead to persistent complaints or recurrent instability due to failure of reconstruction.Therefore, it is of utmost importance to identify infections at an early stage, or better, to prevent them.The use of benzoyl peroxide gel preoperatively seems effective in reducing early c.Acnes infections in this type of surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
MDR Report Key12749008
MDR Text Key285414611
Report Number2210968-2021-10853
Device Sequence Number1
Product Code NEW
Combination Product (y/n)N
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial
Report Date 11/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/19/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-